[Lung cancer: epidemiology and screening]

Area of Science:

• Oncology
• Public Health
• Epidemiology

Background:

• Lung cancer is a leading cause of cancer incidence and mortality in France.
• The epidemiology of lung cancer is evolving, influenced by therapeutic advancements and risk factors like tobacco smoking.
• A significant proportion of lung cancer cases are diagnosed at a metastatic stage, limiting treatment efficacy and survival.

Purpose of the Study:

• To provide an overview of lung cancer epidemiology in France.
• To highlight the impact of early diagnosis and therapeutic innovations on lung cancer outcomes.
• To discuss the potential benefits of implementing screening programs for high-risk populations, particularly smokers.

Main Methods:

• Epidemiological data analysis for lung cancer incidence in France.
• Review of current therapeutic strategies and their impact on mortality.
• Assessment of survival rates based on diagnostic stage (early vs. metastatic).

Main Results:

• An estimated 39,495 lung cancer cases were recorded in France in 2012.
• Lung cancer ranks as the second most common cancer in men and third in women.
• Early-stage diagnosis, amenable to surgical resection, offers a 5-year survival rate exceeding 85%.

Conclusions:

• Lung cancer remains a significant public health concern in France.
• Therapeutic innovations are contributing to reduced mortality rates.
• The high survival rate for early-stage lung cancer underscores the importance of considering screening strategies for smokers.